SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about newspaper advertisements

03 Sep 2024 Evaluate

Pursuant to Regulation 47 and 30 read with Para A of Schedule III of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that it enclosed the Notice of 31st Annual General Meeting (AGM) published in newspapers, ‘The Financial Express (English)’ and ‘Jansatta (Hindi)’ on September 02, 2024.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

258.50 10.00 (4.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×